Xtx Topco LTD Coherus Bio Sciences, Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 91,739 shares of CHRS stock, worth $156,873. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,739
Previous 55,482
65.35%
Holding current value
$156,873
Previous $44,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CHRS
# of Institutions
119Shares Held
58.2MCall Options Held
89.3KPut Options Held
31K-
Black Rock Inc. New York, NY11.8MShares$20.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$18.1 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$8.72 Million0.22% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$5.19 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA2.68MShares$4.58 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $133M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...